Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

5.08
Delayed Data
As of 1:54pm ET
 +0.28 / +5.83%
Today’s Change
0.65
Today|||52-Week Range
5.76
+128.83%
Year-to-Date

Today’s Trading

Previous close4.80
Today’s open4.89
Day’s range4.78 - 5.14
Volume69,283
Average volume (3 months)88,181
Market cap$106.9M
Dividend yield--
Data as of 1:54pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-1,950.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.02-1.17%
SNSSSunesis Pharmaceutic...-0.02-1.43%
CPIXCumberland Pharmaceu...-0.22-3.53%
JNPJuniper Pharmaceutic...+0.13+1.27%
Data as of 2:08pm ET, 08/03/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$5.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Financial Officer
William Hornung
Corporate headquarters
Edison, New Jersey

Forecasts